Efficacy comparison of rosuvastatin vs simvastatin on blood lipid and microinflammatory state in the maintenance hemodialysis patients

Objective To compared the efficacy of rosuvastatin vs simvastatin on blood lipid and microinflammatory state in maintenance hemodialysis( MHD) patients. Methods Seventy-eight MHD patients were enrolled between Feb. 2015 to Mar. 2016,and divided into two groups: rosuvastatin group and simvastatin gro...

Full description

Saved in:
Bibliographic Details
Main Authors: XU Fang, NIE Da-qing, CHEN Wen-li, LI Li
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Nephrology 2017-01-01
Series:Linchuang shenzangbing zazhi
Subjects:
Online Access:http://www.lcszb.com/thesisDetails?columnId=57916740&Fpath=home&index=0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849323530960764928
author XU Fang
NIE Da-qing
CHEN Wen-li
LI Li
author_facet XU Fang
NIE Da-qing
CHEN Wen-li
LI Li
author_sort XU Fang
collection DOAJ
description Objective To compared the efficacy of rosuvastatin vs simvastatin on blood lipid and microinflammatory state in maintenance hemodialysis( MHD) patients. Methods Seventy-eight MHD patients were enrolled between Feb. 2015 to Mar. 2016,and divided into two groups: rosuvastatin group and simvastatin group. Rosuvastatin group was treated with high flux hemodialysis therapy and rosuvastatin( 10 mg,once every for 6 months). Simvastatin group was given high flux hemodialysis therapy and simvastatin( 20 mg,once every day for 6 months). The general information,microinflammatory index and serum lipids were compared between two groups. Results There was no significant difference between two groups in terms of age,time of hemodialysis,BMI,Hb,MQSGA score and primary diseases. As compared with before therapy,hs-CRP,TNF-α,IL-6,TC,TG and LDL-C were significantly decreased in rosuvastatin groupafter treatment for 6 months. The levels of hs-CRP,IL-6 and TNF-( in rosuvastatin group were significantly lower than those in simvastatin group after treatment for 6 months [( 2. 25 ± 1. 21) vs( 3. 34 ± 2. 02),P =0. 004;( 7. 28 ± 3. 68) vs( 10. 17 ± 3. 69),P < 0. 001;( 2. 14 ± 0. 86) vs( 5. 24 ± 1. 18),P < 0. 001,respectively]. The level of HDL-C was significantly increased in these two groups after treatment for 6 months as compared with that before treatment. However,there was no significant difference between these two groups in terms of HDL-C after treatment for 6 months. Conclusions Rosuvastatin is better than simvastatin in the treatment of MHD patients.
format Article
id doaj-art-fa710748efec40a7bf605f73de31f7d7
institution Kabale University
issn 1671-2390
language zho
publishDate 2017-01-01
publisher Editorial Department of Journal of Clinical Nephrology
record_format Article
series Linchuang shenzangbing zazhi
spelling doaj-art-fa710748efec40a7bf605f73de31f7d72025-08-20T03:49:02ZzhoEditorial Department of Journal of Clinical NephrologyLinchuang shenzangbing zazhi1671-23902017-01-0147147657916740Efficacy comparison of rosuvastatin vs simvastatin on blood lipid and microinflammatory state in the maintenance hemodialysis patientsXU FangNIE Da-qingCHEN Wen-liLI LiObjective To compared the efficacy of rosuvastatin vs simvastatin on blood lipid and microinflammatory state in maintenance hemodialysis( MHD) patients. Methods Seventy-eight MHD patients were enrolled between Feb. 2015 to Mar. 2016,and divided into two groups: rosuvastatin group and simvastatin group. Rosuvastatin group was treated with high flux hemodialysis therapy and rosuvastatin( 10 mg,once every for 6 months). Simvastatin group was given high flux hemodialysis therapy and simvastatin( 20 mg,once every day for 6 months). The general information,microinflammatory index and serum lipids were compared between two groups. Results There was no significant difference between two groups in terms of age,time of hemodialysis,BMI,Hb,MQSGA score and primary diseases. As compared with before therapy,hs-CRP,TNF-α,IL-6,TC,TG and LDL-C were significantly decreased in rosuvastatin groupafter treatment for 6 months. The levels of hs-CRP,IL-6 and TNF-( in rosuvastatin group were significantly lower than those in simvastatin group after treatment for 6 months [( 2. 25 ± 1. 21) vs( 3. 34 ± 2. 02),P =0. 004;( 7. 28 ± 3. 68) vs( 10. 17 ± 3. 69),P < 0. 001;( 2. 14 ± 0. 86) vs( 5. 24 ± 1. 18),P < 0. 001,respectively]. The level of HDL-C was significantly increased in these two groups after treatment for 6 months as compared with that before treatment. However,there was no significant difference between these two groups in terms of HDL-C after treatment for 6 months. Conclusions Rosuvastatin is better than simvastatin in the treatment of MHD patients.http://www.lcszb.com/thesisDetails?columnId=57916740&Fpath=home&index=0RosuvastatinBlood lipidMicroinflammatory stateMaintenance hemodialysis
spellingShingle XU Fang
NIE Da-qing
CHEN Wen-li
LI Li
Efficacy comparison of rosuvastatin vs simvastatin on blood lipid and microinflammatory state in the maintenance hemodialysis patients
Linchuang shenzangbing zazhi
Rosuvastatin
Blood lipid
Microinflammatory state
Maintenance hemodialysis
title Efficacy comparison of rosuvastatin vs simvastatin on blood lipid and microinflammatory state in the maintenance hemodialysis patients
title_full Efficacy comparison of rosuvastatin vs simvastatin on blood lipid and microinflammatory state in the maintenance hemodialysis patients
title_fullStr Efficacy comparison of rosuvastatin vs simvastatin on blood lipid and microinflammatory state in the maintenance hemodialysis patients
title_full_unstemmed Efficacy comparison of rosuvastatin vs simvastatin on blood lipid and microinflammatory state in the maintenance hemodialysis patients
title_short Efficacy comparison of rosuvastatin vs simvastatin on blood lipid and microinflammatory state in the maintenance hemodialysis patients
title_sort efficacy comparison of rosuvastatin vs simvastatin on blood lipid and microinflammatory state in the maintenance hemodialysis patients
topic Rosuvastatin
Blood lipid
Microinflammatory state
Maintenance hemodialysis
url http://www.lcszb.com/thesisDetails?columnId=57916740&Fpath=home&index=0
work_keys_str_mv AT xufang efficacycomparisonofrosuvastatinvssimvastatinonbloodlipidandmicroinflammatorystateinthemaintenancehemodialysispatients
AT niedaqing efficacycomparisonofrosuvastatinvssimvastatinonbloodlipidandmicroinflammatorystateinthemaintenancehemodialysispatients
AT chenwenli efficacycomparisonofrosuvastatinvssimvastatinonbloodlipidandmicroinflammatorystateinthemaintenancehemodialysispatients
AT lili efficacycomparisonofrosuvastatinvssimvastatinonbloodlipidandmicroinflammatorystateinthemaintenancehemodialysispatients